Clinical Trials Sponsored by Hui Li

Total 749 results

LI Taisheng

Unknown

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders (CACTrip12)

HIV

China
Women's Hospital HUS

Not yet recruiting

Early Recovery After Cesarean Delivery - Maternal Glucose Homeostasis Following Preoperative Glucose Dose

Cesarean Section Complications | Gestational Diabetes

Finland
Hua Medicine Limited

Completed

Drug Interaction Study Between Dorzagliatin and Sitagliptin

Patients

United States
Hua Medicine Limited

Completed

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers

Type 2 Diabetes Mellitus

China
Tel Hai College

Completed

Prevention Program- Promoting Self Resilience, Positive Self-Image and Body Image Among Adolescents and Their Parents

Primary Prevention

Israel
Hua Medicine Limited

Completed

Drug Interaction Study Between Dorzagliatin and Empagliflozin

Patients

United States
Hua Medicine Limited

Completed

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

Drug Interaction

China
Tel Hai College

Completed

Intervention Program to Improve Body Image and Self-Esteem Among Female Athletes.

Feeding and Eating Disorders

Israel
Hua Medicine Limited

Completed

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers

Type II Diabetes Mellitus

China
Tel Hai College

Completed

Addressing Body Image Issues While Teaching Academic Course: The Group- Theory and Practice

Body Image | Self Esteem

Israel
Tel Hai College

Completed

Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men (RMR)

Asymptomatic Conditions
Hua Medicine Limited

Completed

Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM

Type 2 Diabetes Mellitus

United States
Hua Medicine Limited

Completed

Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients

Type 2 Diabetes

China
Academia Sinica, Taiwan
National Health Research Institutes, Taiwan; Miao-Li General Hospital, Miao-Li...

Completed

A Pilot Study Comparing Effects of Nutrients Supplements and Dietary Approach in Frailty Management

Frail Elderly
Li Huiping

Not yet recruiting

A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer

Advanced Breast Cancer
Li Xiao Wei

Not yet recruiting

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL) (HAI-TL)

Hepatocellular Carcinoma With PVTT

China
Li-Jen Hsin

Not yet recruiting

Postoperative Pain Management on Uvulopalatopharyngoplasty Patients

Pain, Postoperative | Pain, Acute | Obstructive Sleep Apnea-hypopnea Syndrome
Lei Li

Recruiting

ctDNA Methylation for Detecting Ovarian Cancer

Epithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA Index

China
Lei Li

Recruiting

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Chemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian Cancer

China
Lei Li

Recruiting

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Cervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical Cancer

China
Lei Li

Recruiting

Prognosis of Low-grade Endometrial Stromal Sarcoma

Recurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility Outcomes

China
Lei Li

Recruiting

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1

China
Lei Li

Recruiting

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Chemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound Paclitaxel

China
Li-kun Chen

Recruiting

the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Brain Metastases

China
ShiYue Li

Recruiting

The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in The Pulmonary Periphral Nodule

Diagnosis | Complication Rate

China
Li Zhang, MD

Not yet recruiting

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Non-small Cell Lung Cancer

China
Lei Li

Recruiting

Genetic Mutation in Recurrent Cervical Cancer

Microsatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1

China
Lei Li

Recruiting

Survival Outcomes of Uterine Malignancies in Chinese Population

Endometrial Neoplasms | Survival

China
Lei Li

Unknown

A Training Set for the HRD Model in EOC

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum Resistance

China
Lei Li

Unknown

Immunohistochemical Staining of p16 for the Screening of Cervical Cancer

Cervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic Accuracy

China
Lei Li

Unknown

Cell-free DNA Methylation for Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNA

China
Lei Li

Unknown

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Chemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 Antibody

China
Lei Li

Unknown

Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese

China
Lei Li

Unknown

Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis

Endometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial Tissue

China
Rongrong Li

Unknown

The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease

Iodine Excess in Pregnancy | Selenium Excess in Pregnancy | Iodine Deficiency in Pregnancy | Selenium Deficiency in Pregnancy
Lei Li

Unknown

A Multi-omics Study of Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | Tumorigenesis

China
Lei Li

Unknown

Survival Outcomes of Ovarian Malignancies in Chinese Population

Ovarian Neoplasms | Survival

China
Lei Li

Unknown

Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

Uterine Cervical Neoplasms | Survival

China
Weiqin Li

Unknown

Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis

Pancreatitis, Acute
xiaohua li

Not yet recruiting

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

Gastroesophageal Junction Cancer
Tsung-Ying Li

Recruiting

Vitamin D Deficiency and Body Composition in the Patients With Hemophilia

Hemophilia | Vitamin D Deficiency | Body Composition | Sarcopenia | Osteoporosis | Hemophilic Arthropathy

Taiwan
Lei Li

Recruiting

HRD and Resistance to PAPPi in EOC Patients

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Homologous Recombination Repair Gene Mutation | Drug Resistance | Overall Survival | Progression-free Survival | Poly(ADP-ribose) Polymerase Inhibitor

China
Lei Li

Recruiting

Cervical Cancer Screening Strategies

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection | Cancer Screening | Cervical Cytology

China
Li Zhang, MD

Not yet recruiting

Phase III Study Comparing Osimertinib Monotherapy to Combination Therapy With Osimertinib,Carboplatin and Pemetrexed for Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer With Concurrent EGFR and TP53 Mutations (TOP)

Non-small Cell Carcinoma | EGFR Gene Mutation

China
Lei Li

Recruiting

Different Surgical Approaches in Patients of Early-stage Cervical Cancer

Quality of Life | Mortality | Pelvic Floor Disorders | Laparotomy | Laparoscopy | Cost-Benefit Analysis | Morbidity | Survival | Uterine Cervical Neoplasm

China
Lei Li

Recruiting

Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer

Recurrence | Uterine Cervical Neoplasms | Mortality | Laparotomy | Laparoscopy | Survival

China
LI-JU Chen

Completed

Using Saliva Stimulation to Immediately Improve Heart Failure Inpatient's Thirst Sensation

Heart Failure | Thirst | Saliva

Taiwan
Lei Li

Completed

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Chemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma

China
Lei Li

Completed

First-line Chemotherapy for Recurrent Cervical Cancer

Chemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 Inhibitor

China
Lei Li

Unknown

DNA Methylation Testing for the Screening of Uterine Cervical Lesion

Cervical Cancer | Cervical Intraepithelial Neoplasia | DNA Methylation | Cytology | High-risk Human Papillomavirus

China

Clinical Trials Sponsored by Hui Li

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations